Rachel Ellingson Biolife Solutions Inc (BLFS) insider trading activity

Rachel Ellingson is Director of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 49,825 shares of BLFS, which is worth approximately $1.25 Million. The most recent transaction as insider was on Mar 18, 2025, when has been sold 6,876 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.8K

16.01% 3M change

16.01% 12M change

Total Value Held $1.25 Million

Rachel Ellingson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2025	BUY Grant, award, or other acquisition	-	6,876 Added 12.13%	49,825 Common Stock
Mar 08 2024	BUY Grant, award, or other acquisition	-	11,264 Added 20.78%	42,949 Common Stock
Nov 01 2023	BUY Grant, award, or other acquisition	-	495 Added 1.54%	31,685 Common Stock
Oct 01 2023	BUY Grant, award, or other acquisition	-	362 Added 1.15%	31,190 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	10,187 Added 24.84%	30,828 Common Stock
Aug 01 2022	BUY Grant, award, or other acquisition	-	259 Added 1.24%	20,641 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	341 Added 1.65%	20,382 Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	311 Added 1.53%	20,041 Common Stock
May 06 2022	BUY Grant, award, or other acquisition	-	14,730 Added 42.75%	19,730 Common Stock
Apr 12 2021	BUY Grant, award, or other acquisition	-	5,000 Added 50.0%	5,000 Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

Chief Administrative Officer